Ono Pharmaceutical Co.-Un ADROPHLY
13F holders, Q1 2026 (March 31)6holders +1
1new positions
0sold out
$5.28avg. 13F price*
At the end of Q1 2026, 6 institutions reported holding Ono Pharmaceutical Co.-Un ADR (OPHLY) in their 13F filings, up 1 from Q4 2025. 1 opened new positions and 0 sold out. The largest holders were GAMMA Investing LLC ($257K), Fulton Bank, N.A. ($72K) and Rhumbline Advisers ($29K).
- Company
- Ono Pharmaceutical Co.-Un ADR
- CUSIP
- 682736103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $9K |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 1,746 shares bought and 4,738 shares sold, net −2,992 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| GAMMA Investing LLC | 0.01% | Reduce -1.9% | 48,567 | $257K |
| Fulton Bank, N.A. | 0.00% | No change | 13,604 | $72K |
| Rhumbline Advisers | 0.00% | Reduce -40.4% | 5,575 | $29K |
| Westside Investment Management, Inc. | 0.00% | No change | 3,747 | $20K |
| First Command Advisory Services, Inc. | 0.00% | New | 1,746 | $9K |
| Salomon & Ludwin, LLC | 0.00% | No change | 31 | $164 |
"% of holder's portfolio" is OPHLY's weight in each manager's 13F, not the share of Ono Pharmaceutical Co.-Un ADR the manager owns.